Skip to main content
Log in

Effect of calcium dobesilate on nephropathy in type 2 diabetic rats

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

In order to investigate the effects and mechanisms of calcium dobesilate on renal lesions in experimental type 2 diabetic rats, dibetic rats were randomly divided into control group (group C) and experimental group (group D) treated with calcium dobesitate. The serum creatinine (Scr), protein kinase C (PKC), creatinine clearance (Ccr), transforming growth factor-beta1 (TGF-β1), type IV collagen were compared among the groups after 24 weeks. The renal tissues were observed under light microscopy and electron microscopy. The results showed that after 24 weeks, Scr, PKC, TGF-β1 in group D were significantly lower than in group C, meanwhile, renal pathologic changes in group D were improved. Ccr had no difference between group C and group D. It was concluded that calcium dobesilate could ameliorate renal lesions in diabetic rats through inhibiting PKC and TGF-β1

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rivarola E W, Moyses-Neto M, Dantas Met al. Transforming growth factor-β1 activity in urine of patients with type 2 diabetes and diabetic nephropathy. Braz J Med Bio Res, 1999, 32(12):1525

    Article  CAS  Google Scholar 

  2. Ellis D, Forrest K Y, Erbey Jet al. Urinary measurement of transforming growth factor-β1 and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Clin Chem, 1998, 44:950

    Article  CAS  PubMed  Google Scholar 

  3. Yoya D, King G L. Protein kinase C activation and development of diabetic complication. J Diabetes, 1998, 47:859

    Article  Google Scholar 

  4. Scivittaro V, Ganz M B, Weiss M F. AGEs induce oxidative stress and activate protein kinase C-β II in neonatal mesangial cells. Am J Physiol Renal Physiol, 2000, 278:F676

    Article  CAS  PubMed  Google Scholar 

  5. Brunet J, Farine J C, Garay R Pet al. Angioprotective action of calium dobesilate against reactive oxygen species-induced capillary permeability in the rat. Eur J Pharmacol, 1998, 358:213

    Article  CAS  PubMed  Google Scholar 

  6. Rota R, Chivaroli C, Garay R Pet al. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rat. Eur J Pharmacol, 2004, 495(2–3):217

    Article  CAS  PubMed  Google Scholar 

  7. Koya D, Haneda M, Nakagawa Het al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC-β inhibitor in diabetic db/db mice, a rodent model for type 2 diabeties. FASEB J, 2000, 14:439

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

LIU Xiaocheng, female, born in 1946, Professor

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiaocheng, L., Xinming, L. Effect of calcium dobesilate on nephropathy in type 2 diabetic rats. Current Medical Science 25, 36–38 (2005). https://doi.org/10.1007/BF02831381

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02831381

Key words

Navigation